Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$268.26 - $339.48 $115,351 - $145,976
-430 Reduced 4.96%
8,233 $2.25 Million
Q1 2024

May 08, 2024

SELL
$304.11 - $351.99 $39,230 - $45,406
-129 Reduced 1.47%
8,663 $3 Million
Q4 2023

Jan 31, 2024

BUY
$269.37 - $365.04 $966,499 - $1.31 Million
3,588 Added 68.95%
8,792 $2.84 Million
Q3 2023

Nov 06, 2023

SELL
$350.25 - $422.63 $91,415 - $110,306
-261 Reduced 4.78%
5,204 $1.87 Million
Q2 2023

Jun 20, 2024

SELL
$359.49 - $486.4 $84,120 - $113,817
-234 Reduced 4.11%
5,465 $2.07 Million
Q2 2023

Aug 04, 2023

SELL
$359.49 - $486.4 $84,120 - $113,817
-234 Reduced 4.11%
5,465 $2.07 Million
Q1 2023

Jun 20, 2024

SELL
$418.69 - $503.0 $1.07 Million - $1.29 Million
-2,566 Reduced 31.05%
5,699 $2.73 Million
Q1 2023

Apr 28, 2023

SELL
$418.69 - $503.0 $1.07 Million - $1.29 Million
-2,566 Reduced 31.05%
5,699 $2.73 Million
Q4 2022

Jun 20, 2024

SELL
$351.71 - $456.01 $139,980 - $181,491
-398 Reduced 4.59%
8,265 $3.48 Million
Q4 2022

Feb 09, 2023

BUY
$351.71 - $456.01 $1.09 Million - $1.41 Million
3,085 Added 59.56%
8,265 $3.48 Million
Q3 2022

Nov 10, 2022

BUY
$412.59 - $563.26 $12,790 - $17,461
31 Added 0.6%
5,180 $2.16 Million
Q2 2022

Aug 05, 2022

SELL
$463.67 - $597.16 $86,242 - $111,071
-186 Reduced 3.49%
5,149 $2.56 Million
Q1 2022

May 04, 2022

SELL
$524.57 - $735.42 $521,947 - $731,742
-995 Reduced 15.72%
5,335 $3.06 Million
Q4 2021

Feb 08, 2022

SELL
$708.84 - $794.68 $527,376 - $591,241
-744 Reduced 10.52%
6,330 $4.78 Million
Q3 2021

Nov 15, 2021

SELL
$657.71 - $825.77 $1.51 Million - $1.89 Million
-2,293 Reduced 24.48%
7,074 $5.3 Million
Q2 2021

Aug 10, 2021

SELL
$576.64 - $649.04 $103,795 - $116,827
-180 Reduced 1.89%
9,367 $6.04 Million
Q1 2021

May 06, 2021

BUY
$547.01 - $662.35 $177,778 - $215,263
325 Added 3.52%
9,547 $5.45 Million
Q4 2020

Feb 10, 2021

BUY
$510.68 - $643.45 $1.32 Million - $1.66 Million
2,578 Added 38.8%
9,222 $5.38 Million
Q3 2020

Oct 21, 2020

BUY
$454.43 - $535.6 $238,121 - $280,654
524 Added 8.56%
6,644 $3.43 Million
Q2 2020

Aug 10, 2020

BUY
$334.87 - $493.06 $1.61 Million - $2.37 Million
4,809 Added 366.82%
6,120 $2.76 Million
Q1 2020

May 13, 2020

BUY
$320.01 - $409.07 $54,721 - $69,950
171 Added 15.0%
1,311 $460,000
Q4 2019

Feb 18, 2020

BUY
$319.73 - $374.2 $364,492 - $426,588
1,140 New
1,140 $422,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.41B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Abrdn PLC Portfolio

Follow Abrdn PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

News

Stay updated on Abrdn PLC with notifications on news.